Skip to content

Clinical trials

Phase 3 Sepsis trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Phase: Phase 3 Country / region: Israel Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20101
20121
20131
20161
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting1
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asahi Kasei Pharma America Corporation1
Barzilai Medical Center1
Basilea Pharmaceutica1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Eisai Inc.1
HaEmek Medical Center, Israel1
Jerry Zimmerman1
Rabin Medical Center1
Shionogi1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis10
Shock, Septic3
Pneumonia, Ventilator-Associated2
Staphylococcal Infections2
Systemic Inflammatory Response Syndrome2
Bacteremia1
Candidemia1
Candidiasis1
Candidiasis, Invasive1
Catheter-Related Infections1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.